U.S. markets open in 3 hours 8 minutes
  • S&P Futures

    4,682.50
    -16.50 (-0.35%)
     
  • Dow Futures

    35,626.00
    -120.00 (-0.34%)
     
  • Nasdaq Futures

    16,323.00
    -69.25 (-0.42%)
     
  • Russell 2000 Futures

    2,257.80
    -12.00 (-0.53%)
     
  • Crude Oil

    72.00
    -0.36 (-0.50%)
     
  • Gold

    1,783.00
    -2.50 (-0.14%)
     
  • Silver

    22.31
    -0.13 (-0.57%)
     
  • EUR/USD

    1.1321
    -0.0023 (-0.20%)
     
  • 10-Yr Bond

    1.5090
    0.0000 (0.00%)
     
  • Vix

    20.43
    -1.46 (-6.67%)
     
  • GBP/USD

    1.3187
    -0.0020 (-0.15%)
     
  • USD/JPY

    113.4700
    -0.2670 (-0.23%)
     
  • BTC-USD

    49,148.83
    -176.20 (-0.36%)
     
  • CMC Crypto 200

    1,284.43
    -20.69 (-1.59%)
     
  • FTSE 100

    7,334.27
    -2.78 (-0.04%)
     
  • Nikkei 225

    28,725.47
    -135.15 (-0.47%)
     

Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market

·3 min read
Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The next donnybrook in Alzheimer's disease is looming. Biogen gained the first approval, and a slew of biotech stocks are now lining up.